Annual Total Liabilities
$142.12 M
+$54.63 M+62.45%
December 31, 2024
Summary
- As of March 12, 2025, KNSA annual total liabilities is $142.12 million, with the most recent change of +$54.63 million (+62.45%) on December 31, 2024.
- During the last 3 years, KNSA annual total liabilities has risen by +$94.35 million (+197.55%).
- KNSA annual total liabilities is now at all-time high.
Performance
KNSA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$142.12 M
+$23.82 M+20.14%
December 31, 2024
Summary
- As of March 12, 2025, KNSA quarterly total liabilities is $142.12 million, with the most recent change of +$23.82 million (+20.14%) on December 31, 2024.
- Over the past year, KNSA quarterly total liabilities has stayed the same.
- KNSA quarterly total liabilities is now at all-time high.
Performance
KNSA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
KNSA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +62.5% | 0.0% |
| 3 y3 years | +197.6% | +197.6% |
| 5 y5 years | +388.2% | +388.2% |
KNSA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +197.6% | at high | +197.6% |
| 5 y | 5-year | at high | +388.2% | at high | +601.0% |
| alltime | all time | at high | +388.2% | at high | +636.4% |
Kiniksa Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $142.12 M(+62.5%) | $142.12 M(+20.1%) |
| Sep 2024 | - | $118.29 M(+10.2%) |
| Jun 2024 | - | $107.33 M(+22.3%) |
| Mar 2024 | - | $87.78 M(+0.3%) |
| Dec 2023 | $87.48 M(+37.7%) | $87.48 M(+12.2%) |
| Sep 2023 | - | $77.94 M(+7.2%) |
| Jun 2023 | - | $72.68 M(+37.7%) |
| Mar 2023 | - | $52.77 M(-16.9%) |
| Dec 2022 | $63.52 M(+33.0%) | $63.52 M(-16.4%) |
| Sep 2022 | - | $75.94 M(+33.0%) |
| Jun 2022 | - | $57.08 M(-11.8%) |
| Mar 2022 | - | $64.72 M(+35.5%) |
| Dec 2021 | $47.76 M | $47.76 M(+23.1%) |
| Sep 2021 | - | $38.81 M(-10.6%) |
| Jun 2021 | - | $43.42 M(+7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $40.46 M(+7.8%) |
| Dec 2020 | $37.53 M(+28.9%) | $37.53 M(+44.9%) |
| Sep 2020 | - | $25.90 M(+23.2%) |
| Jun 2020 | - | $21.02 M(+3.7%) |
| Mar 2020 | - | $20.27 M(-30.4%) |
| Dec 2019 | $29.11 M(-31.8%) | $29.11 M(-2.6%) |
| Sep 2019 | - | $29.89 M(-9.2%) |
| Jun 2019 | - | $32.94 M(-16.9%) |
| Mar 2019 | - | $39.64 M(-7.2%) |
| Dec 2018 | $42.70 M(-68.9%) | $42.70 M(+51.5%) |
| Sep 2018 | - | $28.19 M(+20.8%) |
| Jun 2018 | - | $23.33 M(+20.9%) |
| Mar 2018 | - | $19.30 M(-85.9%) |
| Dec 2017 | $137.20 M(+66.9%) | $137.20 M |
| Dec 2016 | $82.20 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual total liabilities year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly total liabilities year-on-year change?
What is Kiniksa Pharmaceuticals annual total liabilities?
The current annual total liabilities of KNSA is $142.12 M
What is the all time high annual total liabilities for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual total liabilities is $142.12 M
What is Kiniksa Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, KNSA annual total liabilities has changed by +$54.63 M (+62.45%)
What is Kiniksa Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of KNSA is $142.12 M
What is the all time high quarterly total liabilities for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly total liabilities is $142.12 M
What is Kiniksa Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, KNSA quarterly total liabilities has changed by $0.00 (0.00%)